Avenique Ltd will hold a board meeting on November 5, 2026, to consider issuing bonus shares to public shareholders. This move is specifically designed to meet regulatory Minimum Public Shareholding (MPS) requirements as mandated by SEBI and the Securities Contracts Rules. Shareholders should await the board's decision regarding the bonus ratio and record date, which will clarify the company's path toward regulatory compliance.
Avenique Ltd Proposes Bonus Issue To Meet MPS Norms
Meeting date: November 5, 2026.
Primary objective: Regulatory compliance via bonus share issuance.
Reader Takeaway: Bonus issue aimed at meeting SEBI MPS rules; investors should monitor the approved ratio and record date.
What just happened
Avenique Ltd has officially notified the BSE that its Board of Directors is scheduled to meet on Thursday, November 5, 2026. The key agenda for this meeting is the consideration and potential approval of a bonus share issuance specifically for the company's public shareholders.
Why this matters
The proposal is a direct response to regulatory requirements regarding the Minimum Public Shareholding (MPS). By increasing the public float through a bonus issue, the company intends to align its equity structure with the mandates set under Rule 19A of the Securities Contracts (Regulation) Rules, 1957, and Regulation 38 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What changes now
This announcement initiates the formal corporate process. As of now, the proposal remains subject to board approval. Should the board greenlight the plan, the subsequent filing will disclose critical details including the bonus ratio and the designated record date for identifying eligible shareholders.
What to track next
Investors should monitor the post-meeting outcome for the following details:
- Official approval confirmation.
- The specific bonus ratio decided by the board.
- The announcement of a record date to determine eligibility for the bonus shares.